“Study the technical validity and feasibility of serum HER-2/Neu and its correlation with tissue HER-2 status in female breast cancer patients only” (2023) Asian Journal of Medical Sciences, 14(11), pp. 228–233. doi:10.3126/ajms.v14i11.55260.